FETROJA

This brand name is authorized in United States. It is also authorized in Estonia.

Active ingredients

The drug FETROJA contains one active pharmaceutical ingredient (API):

1	Cefiderocol UNII TTP8LBP45D - CEFIDEROCOL SULFATE TOSYLATE
	Cefiderocol is a siderophore cephalosporin. In addition to passive diffusion through outer membrane porin channels, cefiderocol is able to bind to extracellular free iron via its siderophore side chain, allowing active transport into the periplasmic space of Gram-negative bacteria through siderophore uptake systems. Cefiderocol subsequently binds to penicillin binding proteins (PBPs), inhibiting bacterial peptidoglycan cell wall synthesis which leads to cell lysis and death.
	Read more about Cefiderocol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FETROJA Powder for solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DI04		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DI Other cephalosporins
Discover more medicines within J01DI04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1887475
US	FDA, National Drug Code	59630-266